CLEC1B and metabolic syndrome: In conclusion, we show a novel, key immunomodulatory role for CLEC-2-podoplanin interaction to limit the accumulation and retention of highly inflamed macrophages in tissues, a major complication observed in many sterile thromboinflammatory diseases such as atherosclerosis and metabolic syndrome.